Vericel (VCEL) Tops Q1 EPS by 17c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. ABBV
4. CL
5. LYB
6. TFII
7. NVT
8. SPY
9. AAPL
10. LITE

Go back to Vericel (VCEL) Tops Q1 EPS by 17c

Vericel Reports First-Quarter 2016 Financial Results

May 10, 2016 7:30 AM EDT

Total Revenues of $14.1 Million Reported for the Quarter

Carticel and Epicel Revenues Increase 31% versus First Quarter 2015

Conference Call Today at 8:00am Eastern Time

CAMBRIDGE, Mass., May 10, 2016 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today reported financial results for the first quarter ended March 31, 2016.

Total net revenues for the quarter ended March 31, 2016 were approximately $14.1 million and included approximately $8.8 million of Carticel net revenues and... More